- Combination of oxaliplatin, fluorouracil, and leucovorin in the treatment of fluoropyrimidine-pretreated patients with metastatic colorectal cancer
-
Lee JH, Lee JH, Kim TW, Lee KH, Kang YK, Lee JS, Kim SH, Kim HC, Yu CS, Kim JC, Kim WK
- KMID: 1066497
- J Korean Med Sci.
- 2001 Feb;16(1):69-74.
- doi: 10.3346/jkms.2001.16.1.69
There has been no standard therapy for patients with metastatic colorectal cancer who have failed to first-line fluorouracil-based treatment. The present study was designed to assess the efficacy and toxicities... -
- CITED
-
- Close
- SHARE
-
- Close
- FOLFIRI as Second-line Chemotherapy after Failure of FOLFOX4 in Advanced Colorectal Cancer: A Korean Single-center Experience
-
Kim JH, Park SJ, Park MI, Moon W, Kim SE, Ku KH, Song SE, Kim JH
- KMID: 1711301
- Korean J Gastroenterol.
- 2014 Jan;63(1):18-24.
- doi: 10.4166/kjg.2014.63.1.18
BACKGROUND/AIMS: The incidence of colorectal cancer has been increasing every year in Korea. Irinotecan- or oxaliplatin-based regimens including biologic agents are known to be effective in patients with advanced colorectal... -
- CITED
-
- Close
- SHARE
-
- Close
- Irinotecan, Continuous 5-Fluorouracil, and Low dose of Leucovorin (modified FOLFIRI) as First Line of Therapy in Recurrent or Metastatic Colorectal Cancer
-
Lee MA, Byun JH, Shim BY, Woo IS, Kang JH, Hong YS, Lee KS, Choi MG, Chang SK, Oh ST, Choi SI, Lee DS
- KMID: 1782231
- Korean J Intern Med.
- 2005 Sep;20(3):205-209.
- doi: 10.3904/kjim.2005.20.3.205
BACKGROUND: Irinotecan, in combination with 5-fluorouracil (5-FU) and a high dose of leucovorin (LV), known as FOLFIRI regimen, has shown activity in recurrent or metastatic colorectal cancer. Therefore, we evaluated... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Severe Bevacizumab-induced Ischemic Pancolitis, Treated with Conservative Management
-
Lee HN, Lee MA, Kim SW, Lim Y, Lee H, Lee HM, Won HS, Chun SH
- KMID: 1792814
- Korean J Gastroenterol.
- 2011 Jul;58(1):42-46.
- doi: 10.4166/kjg.2011.58.1.42
Bevacizumab (Avastin(R)) is a monoclonal antibody against the vascular endothelial growth factor (VEGF) receptor that increases the overall survival rate when added to standard chemotherapy regimens in patients with metastatic... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Advanced Gastric Cancer Presenting as Multiple Colonic Lymphoid Hyperplasia
-
Lee IH, Lee J, Byeon SW, Lee H, Huo S, Yoon SB, Kim JS, Lee SH, Roh SY
- KMID: 2373345
- Korean J Gastroenterol.
- 2015 Oct;66(4):221-226.
- doi: 10.4166/kjg.2015.66.4.221
Gastric cancer frequently disseminates to the liver, lung, and bone via hematogeneous, lymphatic, or peritoneal routes. However, gastric adenocarcinoma that metastasize to the colon and that shows typical linea platisca... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Severe Coronary Spasm Associated with 5-Fluorouracil Chemotherapy
-
Kim SM, Kwak CH, Lee B, Kim SB, Sir JJ, Cho WH, Choi SK
- KMID: 1776527
- Korean J Intern Med.
- 2012 Sep;27(3):342-345.
- doi: 10.3904/kjim.2012.27.3.342
Cardiotoxicity associated with 5-fluorouracil (FU) is an uncommon, but potentially lethal, condition. The case of an 83-year-old man with colon cancer who developed chest pain during 5-FU infusion is presented.... -
- CITED
-
- Close
- SHARE
-
- Close
- A Phase II Study of Cetuximab (Erbitux(R)) plus FOLFIRI for Irinotecan and Oxaliplatin-refractory Metastatic Colorectal Cancer
-
Koo DH, Lee JL, Kim TW, Chang HM, Ryu MH, Lee SS, Kim MK, Sym SJ, Lee JS, Kang YK
- KMID: 1785796
- J Korean Med Sci.
- 2007 Sep;22(Suppl):S98-S103.
- doi: 10.3346/jkms.2007.22.S.S98
We have evaluated the efficacy and safety of cetuximab plus FOLFIRI for irinotecan and oxaliplatin-refractory colorectal cancers. From September 2004 to February 2006, 31 patients with metastatic colorectal cancer were... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Hepatic Arterial Infusion of Fluorouracil with Leucovorin as Salvage Treatment for Refractory Liver Metastases from Colorectal Cancer
-
Lee HJ, Lee YS, Lee KW, Kim SY, Yoon CJ, Shin DY, Lee YG, Choi SY, Kang SG, Kang SB, Kim JH
- KMID: 1036155
- Korean J Intern Med.
- 2011 Mar;26(1):82-88.
- doi: 10.3904/kjim.2011.26.1.82
BACKGROUND/AIMS: Limited options remain for patients with metastatic colorectal cancer (CRC) after failure of standard systemic chemotherapy. Readministration of chemotherapeutic agents by hepatic arterial infusion (HAI) has the rationale of... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-Term Survivals of Stage IIB Osteosarcoma: A 20-Year Experience in a Single Institution
-
Cho Y, Jung GH, Chung SH, Kim JY, Choi Y, Kim JD
- KMID: 999460
- Clin Orthop Surg.
- 2011 Mar;3(1):48-54.
- doi: 10.4055/cios.2011.3.1.48
BACKGROUND: The purpose of this study is to evaluate the disease-free survival (DFS) and overall survival (OS) of patients with stage IIB osteosarcoma at a single institution for 20 years... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic Factors for Metastatic Colorectal Cancer after First-line Chemotherapy with FOLFOX-4 or FOLFIRI Regimen
-
Kim JH, Choi PR, Park SJ, Park MI, Moon W, Kim SE, Lee GW
- KMID: 1791877
- Korean J Gastroenterol.
- 2014 Apr;63(4):209-215.
- doi: 10.4166/kjg.2014.63.4.209
BACKGROUND/AIMS: Information on prognostic factors for metastatic colorectal cancer is an important basis for planning the treatment and predicting the outcomes of the patients; however, it has not been well... -
- CITED
-
- Close
- SHARE
-
- Close
- Phase II Study of Low-dose Paclitaxel and Cisplatin as a Second-line Therapy after 5-Fluorouracil/Platinum Chemotherapy in Gastric Cancer
-
Lee KW, Kim JH, Yun T, Song EK, Na II, Shin H, Oh SY, Choi IS, Oh DY, Kim DW, Im SA, Kim TY, Lee JS, Heo DS, Bang YJ, Kim NK
- KMID: 1785799
- J Korean Med Sci.
- 2007 Sep;22(Suppl):S115-S121.
- doi: 10.3346/jkms.2007.22.S.S115
This study was performed to evaluate the efficacy and toxicity of low-dose paclitaxel/cisplatin chemotherapy in patients with metastatic or recurrent gastric cancer that had failed 5-fluorouracil/platinum-based chemotherapy. Thirty-two patients with... -
- CITED
-
- Close
- SHARE
-
- Close
